Strong Memorial Hospital
Locations
Transplant Summary
Overview
At Strong Memorial Hospital we’ve provided more than 3,000 transplants since our program began in 1989. Our program brings together over 30 years of experience, cutting-edge research, and extensive support services to provide patients and families the best possible treatment options.
Our transplant & cellular therapy program is one of the largest in New York State. It was one of the first programs to be accredited by the Foundation for the Accreditation of Cellular Therapy (FACT). Strong Memorial Hospital has been accredited by the NMDP as a donor Transplant Center since 1992 and is home to an NMDP-approved donor collection center for apheresis and bone marrow harvests.
Our program provides the full spectrum of Cellular Therapies which include blood and marrow transplant care and Immune effector cell therapy. Therapies include haploidentical, cord blood, autologous, and allogeneic transplants, as well as CAR-T cell therapy for eligible patients.This center has been performing allogeneic transplants since 1989 and has been an NMDP transplant center since March 1992.
Attending physicians
Adult - Omar Aljitawi, Eric Huselton, Jane Liesveld, Jozal Moore
Pediatric - Jeff Andolina, John HoranTransplants performed
Marrow/PBSC and double cordCord blood transplants
Adult and pediatricOther programs and services
Ronald McDonald, Hope Lodge, RIT INN, Staybridge INNPatient survival information for this center
This center's actual 1-year survival results are below the expected rate for this center*.The survival information we have for this center includes ONLY:- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 244 patients.The actual 1-year survival of these patients is 70.4%.Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 71% and 81.3%.For help with understanding these statistics, please see Understanding Transplant Outcomes.For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report (Opens in a new tab) at bloodcell.transplant.hrsa.gov.* The expected survival rate for a transplant center can be below, similar to, or above the range listed. This is based on comparing patient survival at all centers that treated patients with similar diseases.
The survival rate cannot tell how you will do with your transplant. Talk to your doctor to understand your prognosis or the likely course of your disease.
Total adult transplants
322
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow6PBSC29Cord blood0Total35Unrelated donorMarrow6PBSC101Cord blood16Total123Total allogeneicMarrow12PBSC130Cord blood16Total158AutologousMarrowBoth marrow & PBSC 164PBSC—Cord blood—Total164Total combinedMarrowBoth marrow & PBSC 306PBSC—Cord blood16Total322Total pediatric transplants
23
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow6PBSC1Cord blood0Total7Unrelated donorMarrow6PBSC0Cord blood0Total6Total allogeneicMarrow12PBSC1Cord blood0Total13AutologousMarrowBoth marrow & PBSC 10PBSC—Cord blood—Total10Total combinedMarrowBoth marrow & PBSC 23PBSC—Cord blood0Total23All Diseases
Number of transplants by age reported from January 1, 2022 to December 31st, 2023(includes marrow, PBSC and cord blood)
0-18 19-44 45-64 65+ Total Related 0-18719-441045-641765+8Total42Unrelated 0-18619-442445-645665+43Total129Autologous 0-181119-442245-646865+73Total174Total 0-182419-445645-6414165+124Total345Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants can be found:
- U.S. Transplant Data by Center (Opens in a new tab) report at blood cell.transplant.hrsa.gov
- List of diseases
Transplant center resources
Transplant center coordinatorSharon SwiftPhone: (585) 275-2262NMDP patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
- Inside the United States: 1 (888) 999-6743
- Outside the United States: 1 (763) 406-3410. (Long distance or international charges may apply.)
Email: patientinfo@nmdp.org
More resources
- Choosing a transplant center
- Preparing for transplant
- Learn about transplant outcomes and treatment decisions (Opens in a new tab)
- Support and resources (including non-English materials)
- U.S. Transplant Data by Center (Opens in a new tab) at blood cell.transplant.hrsa.gov
University of Rochester
Box 704 601 Elmwood Avenue Rochester, NY 14642 Phone:585-275-5683 Physician Referrals:585-275-5830 For more information about this program: https://www.urmc.rochester.edu/cancer-institute/services/bmt.aspx (Opens in a new tab)Staff
Program Director:Patrick Reagan, MDProgram Coordinator:Margaret Blaney, RNMedical Specialties in Program
Allergy/immunology, cardiology, complementary and alternative medicine, dentistry, dermatology, endocrinology, gastroenterology, gynecology, hematology, infectious disease, nephrology, oncology, ophthalmology/optometry, palliative care, psychiatry/psychology.Medical Services Offered
Chronic GVHD management, fertility counseling, reproductive health, nutrition/dietetics, pain management, social services, vaccinations.Telemedicine services are available.Patient Eligibility
Adults- Allogeneic and Autologous transplant recipients
- Adults: 6 months after transplant.
- Adults (over age 18)
- Will provide care to adult patients who underwent transplant as a child
- Does accept patients who were transplanted at another hospital